Ares Capital (NASDAQ:ARCC) versus Bain Capital Specialty Finance (NYSE:BCSF) Financial Analysis

Bain Capital Specialty Finance (NYSE:BCSFGet Free Report) and Ares Capital (NASDAQ:ARCCGet Free Report) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Bain Capital Specialty Finance and Ares Capital, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bain Capital Specialty Finance 0 1 2 0 2.67
Ares Capital 0 3 7 0 2.70

Bain Capital Specialty Finance presently has a consensus target price of $15.50, suggesting a potential upside of 11.55%. Ares Capital has a consensus target price of $22.25, suggesting a potential upside of 11.65%. Given Ares Capital’s stronger consensus rating and higher possible upside, analysts plainly believe Ares Capital is more favorable than Bain Capital Specialty Finance.

Insider & Institutional Ownership

27.4% of Ares Capital shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by insiders. Comparatively, 0.5% of Ares Capital shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

Bain Capital Specialty Finance has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Ares Capital has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Valuation and Earnings

This table compares Bain Capital Specialty Finance and Ares Capital”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bain Capital Specialty Finance $292.65 million 3.08 $119.42 million $1.44 9.65
Ares Capital $1.57 billion 9.07 $1.52 billion $2.00 9.96

Ares Capital has higher revenue and earnings than Bain Capital Specialty Finance. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Ares Capital, indicating that it is currently the more affordable of the two stocks.

Dividends

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 12.1%. Ares Capital pays an annual dividend of $1.92 per share and has a dividend yield of 9.6%. Bain Capital Specialty Finance pays out 116.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ares Capital pays out 96.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Profitability

This table compares Bain Capital Specialty Finance and Ares Capital’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bain Capital Specialty Finance 33.45% 11.03% 4.66%
Ares Capital 45.16% 10.08% 4.80%

Summary

Ares Capital beats Bain Capital Specialty Finance on 12 of the 17 factors compared between the two stocks.

About Bain Capital Specialty Finance

(Get Free Report)

Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.

About Ares Capital

(Get Free Report)

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Receive News & Ratings for Bain Capital Specialty Finance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bain Capital Specialty Finance and related companies with MarketBeat.com's FREE daily email newsletter.